These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Binding of ETS family members is important for the function of the c-sis/platelet-derived growth factor-B TATA neighboring sequence in 12-O-tetradecanoylphorbol-13-acetate-treated K562 cells. Kujoth GC; Robinson DF; Fahl WE Cell Growth Differ; 1998 Jul; 9(7):523-34. PubMed ID: 9690620 [TBL] [Abstract][Full Text] [Related]
24. Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors. Versnel MA; Hagemeijer A; Bouts MJ; van der Kwast TH; Hoogsteden HC Oncogene; 1988 Jun; 2(6):601-5. PubMed ID: 3290807 [TBL] [Abstract][Full Text] [Related]
26. PDGF-D is a potent transforming and angiogenic growth factor. Li H; Fredriksson L; Li X; Eriksson U Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513 [TBL] [Abstract][Full Text] [Related]
27. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT). Taniguchi Y; Sasaki S Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068 [TBL] [Abstract][Full Text] [Related]
28. Growth factor production by human thyroid carcinoma cells: abundant expression of a platelet-derived growth factor-B-like protein by a human papillary carcinoma cell line. Matsuo K; Tang SH; Sharifi B; Rubin SA; Schreck R; Fagin JA J Clin Endocrinol Metab; 1993 Oct; 77(4):996-1004. PubMed ID: 8408476 [TBL] [Abstract][Full Text] [Related]
29. The half-lives of platelet-derived growth factor A- and B-chain mRNAs are similar in endothelial cells and unaffected by heparin-binding growth factor-1 or cycloheximide. Gay CG; Winkles JA J Cell Physiol; 1991 Apr; 147(1):121-7. PubMed ID: 1709940 [TBL] [Abstract][Full Text] [Related]
30. 5' untranslated sequences determine degradative pathway for alternate PDGF B/c-sis mRNA's. Fen Z; Daniel TO Oncogene; 1991 Jun; 6(6):953-9. PubMed ID: 2067847 [TBL] [Abstract][Full Text] [Related]
31. Growth factor PDGF-B/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism. Potapova O; Fakhrai H; Mercola D Int J Cancer; 1996 May; 66(5):669-77. PubMed ID: 8647631 [TBL] [Abstract][Full Text] [Related]
32. Spontaneous expression of the c-sis gene and release of a platelet-derived growth factorlike molecule by human alveolar macrophages. Mornex JF; Martinet Y; Yamauchi K; Bitterman PB; Grotendorst GR; Chytil-Weir A; Martin GR; Crystal RG J Clin Invest; 1986 Jul; 78(1):61-6. PubMed ID: 3722386 [TBL] [Abstract][Full Text] [Related]
33. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2. Sonobe MH; Bravo R; Armelin MS Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519 [TBL] [Abstract][Full Text] [Related]
34. Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Martinet Y; Bitterman PB; Mornex JF; Grotendorst GR; Martin GR; Crystal RG Nature; 1986 Jan 9-15; 319(6049):158-60. PubMed ID: 3941744 [TBL] [Abstract][Full Text] [Related]
35. Modulation of platelet-derived growth factor A- and B-chain/c-sis mRNA by tumor necrosis factor and other agents in adenocarcinoma cells. Kalthoff H; Roeder C; Humburg I; Thiele HG; Greten H; Schmiegel W Oncogene; 1991 Jun; 6(6):1015-21. PubMed ID: 1906154 [TBL] [Abstract][Full Text] [Related]
36. Identification of platelet-derived growth factor A and B chains in human renal vascular rejection. Alpers CE; Davis CL; Barr D; Marsh CL; Hudkins KL Am J Pathol; 1996 Feb; 148(2):439-51. PubMed ID: 8579107 [TBL] [Abstract][Full Text] [Related]
37. Ets-1 stimulates platelet-derived growth factor A-chain gene transcription and vascular smooth muscle cell growth via cooperative interactions with Sp1. Santiago FS; Khachigian LM Circ Res; 2004 Sep; 95(5):479-87. PubMed ID: 15297375 [TBL] [Abstract][Full Text] [Related]
38. The human c-Src proto-oncogene promoter contains multiple targets for triplex-forming oligonucleotides. Ritchie S; Bonham K Antisense Nucleic Acid Drug Dev; 1998 Oct; 8(5):391-400. PubMed ID: 9826266 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex. Kim HG; Reddoch JF; Mayfield C; Ebbinghaus S; Vigneswaran N; Thomas S; Jones DE; Miller DM Biochemistry; 1998 Feb; 37(8):2299-304. PubMed ID: 9485376 [TBL] [Abstract][Full Text] [Related]
40. Induction of platelet-derived growth factor B/c-sis by the v-erbA oncogene in glial cells. Iglesias T; Llanos S; López-Barahona M; Seliger B; Rodríguez-Peña A; Bernal J; Muñoz A Oncogene; 1995 Mar; 10(6):1103-10. PubMed ID: 7700635 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]